Author:
Jagadisan Barath,Dhawan Anil
Abstract
Abstract
Research on biomarkers in BA promises to predict and change outcomes in BA. This goal is still unrealized at the moment. The study by Kamp et al attempts to understand the drivers of fibrosis and elucidate the role of amyloid-related genes in the pathophysiology of BA. Based on this, they attempt to predict outcomes in BA using biomarkers by analysing plasma samples for amyloid precursor protein. There is a need to evaluate if shifting the focus from pre-KPE biomarkers to post-KPE biomarkers, serial evaluations and the use of composite scores could help in better prognostication.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Annual report on liver transplantation - Report for 2022/2023. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/30875/nhsbt-liver-transplantation-report-2223.pdf. NHS Blood and transplant - NHS England.
2. Shneider, B. L. et al. Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. J. Pediatr. 170, 211–7.e1-2 (2016).
3. Sundaram, S. S., Mack, C. L., Feldman, A. G. & Sokol, R. J. Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care. Liver Transpl. 23, 96–109 (2017).
4. Jain, V. et al. Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood. J. Hepatol. 71, 71–77 (2019).
5. Chardot, C. et al. Is the Kasai operation still indicated in children older than 3 months diagnosed with biliary atresia? J. Pediatr. 138, 224–228 (2001).